Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03571737 · ClinicalTrials.gov registry record · Phase 3
Efficacy of Lidocaine Patch in Acute Musculoskeletal Pain in the Emergency Department
A Phase 3 study of Trauma and Acute Pain, sponsored by East Carolina University.
- Completed
- Registry status
- Phase 3
- Development phase
- 23
- Enrollment target
- 1
- Study location
NCT03571737: Completed Phase 3 study of Trauma and Acute Pain, sponsored by East Carolina University.
NCT03571737 is a Phase 3 study of Trauma and Acute Pain that has completed, run by East Carolina University. The registered enrollment target is 23 participants, below the 307-participant average among 56 other Trauma trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03571737, a Phase 3 study of Trauma and Acute Pain, has completed, sponsored by East Carolina University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 23 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates the addition of a lidocaine patch to ibuprofen in the treatment of acute musculoskeletal pains. Half of the participants will get only ibuprofen for their pain, while other half will receive lidocaine patch plus the ibuprofen. After addition of the pain medications, the participants will be followed for their pain scores and return visits.
Primary Outcome
Change in self-reported pain intensity level. Baseline will be prior to intervention, and change will be assessed 60 minutes after intervention. Each item is scored 0-10 (0=No pain, 10= Worst pain possible). Higher number is worse outcome while lower number is better outcome.
Conditions Studied
Interventions
- DRUG Ibuprofen
- DRUG Lidocaine Patch 4%
Study Locations (1)
North Carolina
- Vidant Medical Center - Greenville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2018-06-23 |
| Est. Completion | 2021-01-30 |
| Phase | Phase 3 |
What the finished NCT03571737 record still lists
NCT03571737 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 307-participant average among 56 other Trauma trials with a reported enrollment target (93% lower).
The record links to 7 conditions, with Trauma appearing as the primary indexed condition, and to 2 interventions - of which Ibuprofen is the first listed.
NCT03571737 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT03571737 about?
NCT03571737 is a clinical study titled "Efficacy of Lidocaine Patch in Acute Musculoskeletal Pain in the Emergency Department". This study evaluates the addition of a lidocaine patch to ibuprofen in the treatment of acute musculoskeletal pains. Half of the participants will get only ibuprofen for their pain, while other half will receive lidocaine patch plus the ibuprofen. After addition of the pain medications, the particip...
What is the current status of trial NCT03571737?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 23 participants. The study started on 2018-06-23. Estimated completion is 2021-01-30.
What conditions does trial NCT03571737 study?
This clinical trial studies the following conditions: Trauma, Acute Pain, Emergencies, Injuries, Sprains and Strains.
What interventions are being tested in trial NCT03571737?
The interventions under investigation include: Ibuprofen (DRUG), Lidocaine Patch 4% (DRUG).
Who is sponsoring clinical trial NCT03571737?
This trial is sponsored by East Carolina University, which has 58 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03571737 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Trauma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03571737's enrollment target sits among peer trials
23 49th of 56 higher than 8 of 56 other Trauma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Trauma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Supplemental Enteral Protein in Critical Illness
COMPLETED · Phase 3
-
CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial
RECRUITING · Phase 2
-
Testing FIRST in Youth Outpatient Psychotherapy
RECRUITING · NA
-
PRESERVE & CONNECT: Impact Study of the BPC
RECRUITING · NA
-
Multiphase Optimization Strategy (MOST) for Treating Pediatric Post-traumatic Stress Disorder (PTSD)
RECRUITING · NA
-
PMCF Study to Evaluate the VERTICALE® Cervical System in Spine Surgery According to Its Intended Use.
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI